Free Trial

Transcat (TRNS) Financials

Transcat logo
$90.16 -1.44 (-1.57%)
As of 12:27 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Transcat

Annual Income Statements for Transcat

This table shows Transcat's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/26/2016 3/25/2017 3/31/2018 3/30/2019 3/28/2020 3/27/2021 3/26/2022 3/25/2023 3/30/2024 3/29/2025 3/28/2026
Net Income / (Loss) Attributable to Common Shareholders
4.12 4.52 5.92 7.15 8.07 7.79 11 11 14 15 5.38
Consolidated Net Income / (Loss)
4.12 4.52 5.92 7.15 8.07 7.79 11 11 14 15 5.38
Net Income / (Loss) Continuing Operations
4.12 4.52 5.92 7.15 8.07 7.79 11 11 14 15 5.38
Total Pre-Tax Income
6.01 7.16 7.95 9.24 9.73 9.98 13 13 18 18 7.99
Total Operating Income
6.30 7.93 9.03 10 11 11 14 16 20 18 13
Total Gross Profit
29 35 37 39 42 46 58 68 84 89 108
Total Revenue
122 144 155 161 173 173 205 231 259 278 332
Operating Revenue
122 144 155 161 173 173 205 231 259 278 332
Total Cost of Revenue
93 109 118 122 131 127 147 162 176 189 224
Operating Cost of Revenue
93 109 118 122 131 127 147 162 176 189 224
Total Operating Expenses
23 27 28 29 32 35 44 52 64 72 95
Selling, General & Admin Expense
9.19 10 12 12 14 17 24 27 35 38 52
Marketing Expense
14 17 17 17 18 18 21 25 29 33 43
Total Other Income / (Expense), net
-0.30 -0.77 -1.08 -0.99 -1.12 -1.09 -0.95 -2.76 -1.34 0.45 -5.27
Interest Expense
- - - - - - 0.81 2.42 1.84 0.80 4.60
Interest & Investment Income
- - - - - - 0.00 0.00 0.81 0.83 0.02
Other Income / (Expense), net
-0.30 -0.77 -1.08 -0.99 -1.12 -1.09 -0.14 -0.34 -0.32 0.43 -0.70
Income Tax Expense
1.88 2.64 2.03 2.09 1.66 2.19 1.81 2.80 4.79 3.81 2.61
Basic Earnings per Share
$0.60 $0.65 $0.83 $0.99 $1.10 $1.05 $1.52 $1.42 $1.66 $1.58 $0.58
Weighted Average Basic Shares Outstanding
6.89M 6.99M 7.12M 7.20M 7.33M 7.42M 7.50M 7.55M 8.24M 9.19M 9.33M
Diluted Earnings per Share
$0.58 $0.64 $0.81 $0.95 $1.08 $1.03 $1.50 $1.40 $1.63 $1.57 $0.57
Weighted Average Diluted Shares Outstanding
7.12M 7.11M 7.30M 7.52M 7.49M 7.55M 7.59M 7.65M 8.35M 9.25M 9.38M
Weighted Average Basic & Diluted Shares Outstanding
6.98M 7.11M 7.20M 7.30M 7.39M 7.47M 7.55M 7.64M 9.13M 9.32M 9.34M

Quarterly Income Statements for Transcat

This table shows Transcat's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 9/23/2023 12/23/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026
Net Income / (Loss) Attributable to Common Shareholders
0.46 3.35 6.89 4.41 3.29 2.36 4.46 3.26 1.27 -1.10 1.95
Consolidated Net Income / (Loss)
0.46 3.35 6.89 4.41 3.29 2.36 4.46 3.26 1.27 -1.10 1.95
Net Income / (Loss) Continuing Operations
0.46 3.35 6.89 4.41 3.29 2.36 4.46 3.26 1.27 -1.10 1.95
Total Pre-Tax Income
0.80 4.27 9.60 5.23 3.71 3.13 6.26 4.57 2.03 -1.44 2.83
Total Operating Income
1.64 4.29 9.20 5.10 3.74 2.10 6.94 5.34 3.51 0.09 4.33
Total Gross Profit
20 21 24 23 21 20 26 26 27 25 30
Total Revenue
63 65 71 67 68 67 77 76 82 84 89
Operating Revenue
63 65 71 67 68 67 77 76 82 84 89
Total Cost of Revenue
43 44 47 44 47 47 51 51 56 59 59
Operating Cost of Revenue
43 44 47 44 47 47 51 51 56 59 59
Total Operating Expenses
18 17 15 18 17 18 19 20 23 25 26
Selling, General & Admin Expense
12 9.12 6.97 9.76 9.29 9.46 9.73 11 13 14 15
Marketing Expense
6.86 7.52 7.87 7.80 8.18 8.12 9.24 9.52 11 11 11
Total Other Income / (Expense), net
-0.84 -0.02 0.40 0.13 -0.02 1.03 -0.68 -0.77 -1.48 -1.53 -1.50
Interest Expense
0.89 0.08 - 0.05 0.08 0.20 0.47 0.45 1.27 1.50 1.38
Interest & Investment Income
0.00 0.35 - 0.31 0.29 0.22 0.01 0.01 0.01 0.00 0.00
Other Income / (Expense), net
0.05 -0.29 0.88 -0.13 -0.23 1.01 -0.22 -0.33 -0.21 -0.03 -0.12
Income Tax Expense
0.34 0.92 2.71 0.82 0.43 0.77 1.79 1.30 0.76 -0.34 0.89
Basic Earnings per Share
$0.06 $0.39 $0.82 $0.49 $0.36 $0.26 $0.47 $0.35 $0.14 ($0.12) $0.21
Weighted Average Basic Shares Outstanding
7.82M 8.62M 8.24M 9.06M 9.16M 9.23M 9.19M 9.32M 9.32M 9.33M 9.33M
Diluted Earnings per Share
$0.06 $0.38 $0.81 $0.48 $0.35 $0.25 $0.49 $0.35 $0.14 ($0.12) $0.20
Weighted Average Diluted Shares Outstanding
7.95M 8.75M 8.35M 9.20M 9.28M 9.33M 9.25M 9.39M 9.40M 9.33M 9.38M
Weighted Average Basic & Diluted Shares Outstanding
8.83M 8.83M 9.13M 9.15M 9.20M 9.31M 9.32M 9.32M 9.33M 9.33M 9.34M

Annual Cash Flow Statements for Transcat

This table details how cash moves in and out of Transcat's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/26/2016 3/25/2017 3/31/2018 3/30/2019 3/28/2020 3/27/2021 3/26/2022 3/25/2023 3/30/2024 3/29/2025 3/28/2026
Net Change in Cash & Equivalents
0.58 0.20 -0.27 0.21 -0.29 0.06 0.84 0.14 18 -18 3.43
Net Cash From Operating Activities
11 7.54 9.87 13 12 24 18 17 33 39 35
Net Cash From Continuing Operating Activities
11 7.54 9.87 13 12 24 18 17 33 39 35
Net Income / (Loss) Continuing Operations
4.12 4.52 5.92 7.15 8.07 7.79 11 11 14 15 5.38
Consolidated Net Income / (Loss)
4.12 4.52 5.92 7.15 8.07 7.79 11 11 14 15 5.38
Depreciation Expense
3.95 6.18 5.99 6.36 6.66 7.58 9.57 11 14 19 26
Amortization Expense
- - - - - - - - 0.00 0.00 0.10
Non-Cash Adjustments To Reconcile Net Income
0.54 0.83 1.64 1.63 1.72 2.29 2.45 3.54 5.74 6.15 14
Changes in Operating Assets and Liabilities, net
2.37 -3.99 -3.68 -2.58 -4.88 5.98 -5.78 -8.23 -0.31 -0.24 -11
Net Cash From Investing Activities
-18 -12 -5.87 -11 -20 -10 -40 -19 -42 -84 -98
Net Cash From Continuing Investing Activities
-18 -12 -5.87 -11 -20 -10 -40 -19 -42 -84 -98
Purchase of Property, Plant & Equipment
-4.10 -5.25 -5.88 -7.00 -6.58 -6.62 -10 -9.41 -13 -13 -15
Acquisitions
-14 -6.98 0.00 -3.92 -14 -3.55 -30 -9.11 -13 -87 -83
Sale of Property, Plant & Equipment
0.03 0.06 0.01 0.02 0.18 0.02 0.11 0.01 0.00 1.10 0.00
Sale and/or Maturity of Investments
- - - - - - - - -16 16 0.00
Net Cash From Financing Activities
7.23 4.77 -3.98 -1.71 8.25 -13 24 0.88 27 27 67
Net Cash From Continuing Financing Activities
7.23 4.77 -3.98 -1.71 8.25 -13 24 0.88 27 27 67
Repayment of Debt
0.00 -1.76 -12 -4.35 -1.90 -1.98 -2.11 0.67 -103 -40 -90
Repurchase of Common Equity
-0.13 -1.06 -0.45 -0.15 -2.82 -3.05 -6.68 -0.45 -4.91 -3.57 -0.47
Issuance of Debt
6.91 10 7.14 2.50 11 -8.80 31 - 58 69 157
Issuance of Common Equity
0.45 0.64 0.93 0.29 1.73 1.18 1.49 0.66 77 1.87 0.84
Other Financing Activities, net
0.00 -3.04 - - - - - - 0.00 0.00 -0.28
Effect of Exchange Rate Changes
0.33 0.06 -0.29 0.26 0.15 - - 0.82 -0.23 0.02 -0.10
Cash Interest Paid
0.24 0.69 1.02 0.91 0.94 0.86 0.78 2.26 1.24 -0.15 4.18
Cash Income Taxes Paid
1.29 1.84 2.07 1.30 1.37 1.76 3.90 1.12 3.10 7.84 2.22

Quarterly Cash Flow Statements for Transcat

This table details how cash moves in and out of Transcat's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 9/23/2023 12/23/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026
Net Change in Cash & Equivalents
-0.90 34 -16 3.01 1.16 -19 -3.12 0.34 3.22 -1.61 1.47
Net Cash From Operating Activities
8.44 11 5.73 8.92 6.84 13 11 3.62 13 12 6.20
Net Cash From Continuing Operating Activities
8.44 11 5.73 8.92 6.73 13 11 3.62 13 12 6.20
Net Income / (Loss) Continuing Operations
0.46 3.35 6.89 4.41 3.29 2.36 4.46 3.26 1.27 -1.10 1.95
Consolidated Net Income / (Loss)
0.46 3.35 6.89 4.41 3.29 2.36 4.46 3.26 1.27 -1.10 1.95
Depreciation Expense
3.29 3.76 3.70 4.11 4.40 4.43 5.63 5.61 6.49 7.13 6.95
Amortization Expense
- - - - - - - - - 0.04 0.04
Non-Cash Adjustments To Reconcile Net Income
1.45 1.21 1.23 1.45 1.07 -0.37 1.40 2.22 3.12 3.30 5.63
Changes in Operating Assets and Liabilities, net
3.24 2.59 -6.10 -1.05 -2.03 6.29 -0.86 -7.46 1.98 2.78 -8.37
Net Cash From Investing Activities
-13 -3.71 -20 -4.09 -3.86 -72 -4.04 -4.60 -87 -2.68 -3.59
Net Cash From Continuing Investing Activities
-13 -3.71 -20 -4.09 -3.86 -72 -4.04 -4.60 -87 -2.68 -3.59
Purchase of Property, Plant & Equipment
-2.68 -3.66 -4.18 -3.67 -3.96 -2.87 -2.70 -4.60 -4.43 -2.68 -3.59
Net Cash From Financing Activities
3.17 27 -1.68 -1.94 -1.41 40 -9.45 1.95 77 -12 -0.49
Net Cash From Continuing Financing Activities
3.17 27 -1.68 -1.94 -1.41 40 -9.45 1.95 77 -12 -0.49
Repayment of Debt
-0.56 -43 -0.57 -0.58 -0.58 39 -9.20 -0.60 -52 -12 -26
Repurchase of Common Equity
-1.95 - -2.66 -1.62 -1.41 -0.18 -0.36 0.00 -0.11 0.01 -0.37
Issuance of Debt
5.49 - - 0.00 - - - 2.29 129 -0.41 26
Issuance of Common Equity
0.19 75 1.55 0.26 0.58 0.93 0.11 0.26 0.23 0.19 0.17
Cash Interest Paid
- - -0.41 0.26 - - 0.46 0.46 0.83 -0.42 3.32
Cash Income Taxes Paid
0.99 0.79 1.22 0.06 5.47 1.33 0.98 -0.18 0.58 1.23 0.59

Annual Balance Sheets for Transcat

This table presents Transcat's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/26/2016 3/25/2017 3/31/2018 3/30/2019 3/28/2020 3/27/2021 3/26/2022 3/25/2023 3/30/2024 3/29/2025 3/28/2026
Total Assets
77 92 97 105 128 132 178 196 288 385 480
Total Current Assets
26 36 41 45 48 49 60 68 105 78 92
Cash & Equivalents
0.64 0.84 0.58 0.79 0.50 0.56 1.40 1.53 20 1.52 4.94
Accounts Receivable
18 23 26 29 32 34 40 45 48 56 66
Inventories, net
6.52 10 13 14 14 12 13 17 17 14 14
Prepaid Expenses
1.10 1.19 1.24 1.33 1.70 2.35 5.30 3.94 4.28 5.70 7.97
Plant, Property, & Equipment, net
12 16 17 20 21 22 26 29 39 50 58
Total Noncurrent Assets
38 41 39 41 59 61 92 99 143 257 330
Goodwill
29 33 33 35 42 43 65 69 106 177 218
Intangible Assets
8.21 7.52 5.51 5.23 7.98 7.51 15 14 20 55 78
Other Noncurrent Operating Assets
0.85 0.90 0.97 0.79 9.31 10 12 16 18 26 34
Total Liabilities & Shareholders' Equity
77 92 97 105 128 132 178 196 288 385 480
Total Liabilities
38 49 45 46 61 57 92 96 62 98 180
Total Current Liabilities
16 20 21 22 21 25 28 28 33 34 40
Short-Term Debt
0.00 1.43 2.14 1.90 1.98 2.07 2.16 2.25 2.34 1.82 0.00
Accounts Payable
8.14 12 14 15 12 12 14 16 11 17 18
Accrued Expenses
- - - - - - 11 10 17 15 22
Total Noncurrent Liabilities
22 29 24 23 40 32 64 68 29 64 140
Long-Term Debt
19 26 21 19 28 17 46 47 1.82 31 100
Noncurrent Deferred & Payable Income Tax Liabilities
1.07 1.13 1.71 2.45 3.03 3.20 6.72 6.54 9.29 9.29 10
Other Noncurrent Operating Liabilities
1.82 1.92 1.91 1.90 8.73 3.24 11 14 18 24 30
Commitments & Contingencies
- - - - - - - - - 0.00 0.00
Total Equity & Noncontrolling Interests
39 43 51 60 67 75 86 100 225 287 301
Total Preferred & Common Equity
39 43 51 60 67 75 86 100 225 287 301
Total Common Equity
39 43 51 60 67 75 86 100 225 287 301
Common Stock
16 17 19 20 22 23 28 32 146 196 204
Retained Earnings
23 27 33 40 46 53 59 69 80 93 98
Accumulated Other Comprehensive Income / (Loss)
-0.36 -0.41 -0.28 -0.61 -1.01 -0.45 -0.23 -1.20 -0.95 -1.47 -0.92

Quarterly Balance Sheets for Transcat

This table presents Transcat's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/24/2022 12/24/2022 6/24/2023 9/23/2023 12/23/2023 6/29/2024 9/28/2024 12/28/2024 6/28/2025 9/27/2025 12/27/2025
Total Assets
187 188 203 248 281 324 324 386 393 485 473
Total Current Assets
63 61 64 65 99 94 95 77 80 86 81
Cash & Equivalents
0.91 1.59 2.15 1.25 35 23 24 4.64 1.86 5.08 3.47
Accounts Receivable
41 38 43 45 44 48 50 52 58 63 60
Inventories, net
17 17 15 16 16 18 16 14 15 13 13
Prepaid Expenses
4.42 4.14 3.39 3.53 3.30 5.07 6.24 5.77 4.04 4.39 4.64
Plant, Property, & Equipment, net
28 28 30 36 37 46 47 50 52 58 58
Total Noncurrent Assets
96 99 110 147 145 183 181 259 261 341 335
Goodwill
66 69 77 106 106 138 138 177 177 218 218
Intangible Assets
15 15 15 23 21 26 24 58 52 85 81
Other Noncurrent Operating Assets
15 16 17 18 18 19 18 25 32 37 35
Total Liabilities & Shareholders' Equity
187 188 203 248 281 324 324 386 393 485 473
Total Liabilities
94 93 93 110 63 61 55 105 100 189 176
Total Current Liabilities
25 25 24 28 29 32 27 32 27 35 37
Short-Term Debt
2.21 2.23 2.27 2.29 2.32 2.36 2.39 2.41 1.22 0.00 0.00
Accounts Payable
14 14 12 13 11 13 13 16 13 15 17
Accrued Expenses
9.09 9.01 9.29 13 16 13 11 13 13 20 19
Total Noncurrent Liabilities
70 68 69 82 33 30 28 73 73 154 140
Long-Term Debt
49 47 46 51 2.41 1.22 0.61 39 33 112 100
Noncurrent Deferred & Payable Income Tax Liabilities
6.67 6.67 7.18 11 11 9.29 9.30 9.26 9.31 9.30 9.31
Other Noncurrent Operating Liabilities
14 14 16 20 20 19 18 24 30 33 30
Total Equity & Noncontrolling Interests
92 95 111 138 218 262 269 281 293 295 297
Total Preferred & Common Equity
92 95 111 138 218 262 269 281 293 295 297
Total Common Equity
92 95 111 138 218 262 269 281 293 295 297
Common Stock
30 31 40 68 145 180 184 195 197 199 201
Retained Earnings
64 66 72 71 74 84 86 88 96 97 96
Accumulated Other Comprehensive Income / (Loss)
-1.52 -1.12 -0.72 -1.06 -0.69 -1.10 -0.72 -1.88 -0.46 -0.75 -0.51

Annual Metrics And Ratios for Transcat

This table displays calculated financial ratios and metrics derived from Transcat's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/26/2016 3/25/2017 3/31/2018 3/30/2019 3/28/2020 3/27/2021 3/26/2022 3/25/2023 3/30/2024 3/29/2025 3/28/2026
DEI Shares Outstanding
- - - - - - - - - - 9,332,188.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 9,332,188.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.58
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-1.18% 17.79% 7.81% 3.71% 7.58% 0.14% 18.24% 12.50% 12.54% 7.30% 19.20%
EBITDA Growth
4.63% 34.11% 4.43% 11.89% 5.08% 7.16% 34.19% 13.97% 22.90% 11.68% 5.37%
EBIT Growth
-6.48% 19.26% 10.94% 16.19% 5.36% 2.59% 40.25% 13.60% 22.40% -6.00% -31.32%
NOPAT Growth
1.99% 15.75% 34.29% 17.68% 13.67% -3.92% 41.19% 5.52% 13.70% -3.30% -36.96%
Net Income Growth
2.43% 9.65% 30.96% 20.65% 12.90% -3.42% 46.07% -6.08% 27.69% 6.36% -62.96%
EPS Growth
1.75% 10.34% 26.56% 17.28% 13.68% -4.63% 45.63% -6.67% 16.43% -3.68% -63.69%
Operating Cash Flow Growth
147.40% -31.31% 30.89% 27.21% -7.96% 104.47% -25.47% -3.79% 92.41% 19.53% -10.61%
Free Cash Flow Firm Growth
-45.73% -14.02% 139.56% -43.16% -578.55% 143.71% -636.89% 94.17% -2,814.24% -239.95% 37.54%
Invested Capital Growth
23.53% 21.85% 5.37% 8.45% 21.40% 5.27% 30.57% 10.50% 31.88% 63.83% 24.36%
Revenue Q/Q Growth
0.43% 4.04% 2.65% 1.28% 0.74% 1.76% 3.60% 2.76% 3.53% 2.29% 3.81%
EBITDA Q/Q Growth
-4.81% 3.92% 6.77% 1.56% 0.76% 6.54% 6.49% 6.37% 16.02% -1.47% -2.71%
EBIT Q/Q Growth
-13.23% 3.18% 13.36% 0.83% 0.44% 8.74% 5.68% 10.91% 22.43% -11.91% -16.65%
NOPAT Q/Q Growth
-6.58% -1.93% 19.05% 3.45% -1.48% 8.83% -0.94% 9.73% 16.86% -10.06% -18.70%
Net Income Q/Q Growth
-7.45% -3.17% 20.93% 2.97% -2.03% 10.10% -1.39% 6.05% 31.03% -14.32% -31.89%
EPS Q/Q Growth
-7.94% -4.48% 19.12% 2.15% -1.82% 9.57% -1.32% 6.06% 25.38% -16.93% -33.72%
Operating Cash Flow Q/Q Growth
3.38% 1.22% 4.08% 11.13% -14.68% 24.59% -13.51% -11.78% 9.21% 14.38% -11.27%
Free Cash Flow Firm Q/Q Growth
-240.06% 51.70% 573.95% -3.28% -258.96% 198.09% -49.30% 89.19% 0.97% 4.23% -7.37%
Invested Capital Q/Q Growth
21.00% 2.65% -0.98% -0.50% 15.00% 6.47% 10.22% 3.05% 3.27% -0.09% 0.60%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
23.84% 24.30% 24.13% 24.45% 24.54% 26.61% 28.51% 29.65% 32.30% 32.13% 32.63%
EBITDA Margin
8.15% 9.28% 8.98% 9.69% 9.47% 10.13% 11.50% 11.65% 12.72% 13.24% 11.70%
Operating Margin
5.16% 5.51% 5.82% 6.36% 6.27% 6.39% 6.90% 7.05% 7.62% 6.42% 4.00%
EBIT Margin
4.92% 4.98% 5.12% 5.74% 5.62% 5.76% 6.83% 6.90% 7.50% 6.57% 3.79%
Profit (Net Income) Margin
3.38% 3.14% 3.82% 4.44% 4.66% 4.49% 5.55% 4.64% 5.26% 5.21% 1.62%
Tax Burden Percent
68.65% 63.12% 74.51% 77.37% 82.91% 78.05% 86.28% 79.25% 74.01% 79.20% 67.29%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 94.21% 84.80% 94.72% 100.15% 63.57%
Effective Tax Rate
31.35% 36.88% 25.49% 22.63% 17.09% 21.95% 13.72% 20.75% 25.99% 20.80% 32.71%
Return on Invested Capital (ROIC)
8.34% 7.87% 9.37% 10.31% 10.18% 8.69% 10.37% 9.18% 8.58% 5.53% 2.50%
ROIC Less NNEP Spread (ROIC-NNEP)
7.01% 5.71% 6.08% 6.69% 6.47% 5.69% 8.15% 4.56% -3.42% 431.72% -3.13%
Return on Net Nonoperating Assets (RNNOA)
2.92% 3.11% 3.13% 2.56% 2.55% 2.27% 3.74% 2.32% -0.17% 0.14% -0.67%
Return on Equity (ROE)
11.26% 10.99% 12.50% 12.88% 12.73% 10.96% 14.11% 11.50% 8.40% 5.67% 1.83%
Cash Return on Invested Capital (CROIC)
-12.71% -11.82% 4.15% 2.20% -9.16% 3.56% -16.15% -0.79% -18.92% -42.86% -19.22%
Operating Return on Assets (OROA)
8.65% 8.49% 8.41% 9.14% 8.34% 7.67% 9.04% 8.52% 8.06% 5.44% 2.90%
Return on Assets (ROA)
5.94% 5.36% 6.27% 7.07% 6.91% 5.99% 7.34% 5.72% 5.65% 4.31% 1.24%
Return on Common Equity (ROCE)
11.26% 10.99% 12.50% 12.88% 12.73% 10.96% 14.11% 11.50% 8.40% 5.67% 1.83%
Return on Equity Simple (ROE_SIMPLE)
10.60% 10.42% 11.53% 11.98% 12.02% 10.38% 13.21% 10.73% 6.06% 5.06% 0.00%
Net Operating Profit after Tax (NOPAT)
4.33 5.01 6.73 7.91 9.00 8.64 12 13 15 14 8.93
NOPAT Margin
3.54% 3.48% 4.33% 4.92% 5.20% 4.99% 5.95% 5.58% 5.64% 5.08% 2.69%
Net Nonoperating Expense Percent (NNEP)
1.33% 2.16% 3.30% 3.62% 3.71% 3.00% 2.22% 4.62% 11.99% -426.20% 5.63%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - 4.43% 2.23%
Cost of Revenue to Revenue
76.16% 75.70% 75.87% 75.55% 75.46% 73.39% 71.49% 70.35% 67.70% 67.87% 67.37%
SG&A Expenses to Revenue
7.52% 7.28% 7.64% 7.56% 7.88% 9.98% 11.54% 11.86% 13.61% 13.73% 15.75%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
18.68% 18.79% 18.32% 18.09% 18.27% 20.22% 21.61% 22.60% 24.67% 25.71% 28.64%
Earnings before Interest and Taxes (EBIT)
6.01 7.16 7.95 9.24 9.73 9.98 14 16 19 18 13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
9.95 13 14 16 16 18 24 27 33 37 39
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 2.78 2.79 5.27 6.48 6.59 4.37 2.38 2.21
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 8.35 10.65 16.30 87.08 39.84 9.88 12.38 140.77
Price to Revenue (P/Rev)
0.00 0.00 0.00 1.03 1.08 2.28 2.72 2.85 3.79 2.45 2.01
Price to Earnings (P/E)
0.00 0.00 0.00 23.19 23.20 50.81 49.05 61.40 72.09 47.06 123.80
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 4.31% 4.31% 1.97% 2.04% 1.63% 1.39% 2.12% 0.81%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 2.33 2.24 4.14 4.54 4.78 4.91 2.25 1.92
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 1.16 1.25 2.44 2.95 3.05 3.67 2.57 2.29
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 11.92 13.24 24.08 25.68 26.21 28.86 19.38 19.58
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 20.13 22.30 42.36 43.23 44.26 48.95 39.04 60.51
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 23.49 24.12 48.93 49.60 54.66 65.08 50.46 85.21
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 14.80 18.77 17.89 34.35 41.52 29.21 18.32 21.82
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 109.92 0.00 119.53 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.49 0.63 0.45 0.35 0.45 0.37 0.56 0.49 0.02 0.11 0.33
Long-Term Debt to Equity
0.49 0.60 0.40 0.32 0.42 0.34 0.54 0.47 0.01 0.11 0.33
Financial Leverage
0.42 0.55 0.51 0.38 0.40 0.40 0.46 0.51 0.05 0.00 0.21
Leverage Ratio
1.90 2.05 1.99 1.82 1.84 1.83 1.92 2.01 1.49 1.31 1.47
Compound Leverage Factor
1.90 2.05 1.99 1.82 1.84 1.83 1.81 1.70 1.41 1.32 0.94
Debt to Total Capital
32.89% 38.62% 30.80% 26.05% 31.14% 26.82% 35.99% 33.02% 1.81% 10.23% 24.94%
Short-Term Debt to Total Capital
0.00% 2.02% 2.89% 2.36% 2.03% 2.01% 1.61% 1.51% 1.02% 0.57% 0.00%
Long-Term Debt to Total Capital
32.89% 36.60% 27.91% 23.69% 29.11% 24.81% 34.38% 31.51% 0.79% 9.67% 24.94%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
67.11% 61.38% 69.20% 73.95% 68.86% 73.18% 64.01% 66.98% 98.19% 89.77% 75.06%
Debt to EBITDA
1.92 2.05 1.64 1.35 1.85 1.57 2.06 1.83 0.13 0.89 2.57
Net Debt to EBITDA
1.85 1.98 1.60 1.30 1.82 1.54 2.00 1.77 -0.94 0.85 2.44
Long-Term Debt to EBITDA
1.92 1.94 1.49 1.22 1.73 1.45 1.96 1.75 0.06 0.84 2.57
Debt to NOPAT
4.41 5.45 3.40 2.65 3.37 3.18 3.97 3.81 0.28 2.31 11.19
Net Debt to NOPAT
4.26 5.29 3.31 2.55 3.32 3.12 3.86 3.70 -2.12 2.20 10.64
Long-Term Debt to NOPAT
4.41 5.17 3.08 2.41 3.15 2.95 3.79 3.64 0.12 2.18 11.19
Altman Z-Score
0.00 0.00 0.00 4.79 4.21 6.50 5.75 6.28 11.28 5.52 3.41
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.66 1.80 1.92 2.03 2.32 1.95 2.15 2.39 3.14 2.29 2.33
Quick Ratio
1.18 1.22 1.26 1.33 1.56 1.39 1.50 1.65 2.49 1.70 1.79
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-6.60 -7.52 2.98 1.69 -8.09 3.54 -19 -1.11 -32 -110 -69
Operating Cash Flow to CapEx
269.83% 145.33% 168.18% 179.91% 180.78% 358.17% 175.43% 180.25% 245.60% 322.27% 227.81%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 -23.45 -0.46 -17.60 -137.55 -14.90
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 21.75 7.01 17.77 48.85 7.57
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 9.35 3.12 10.54 33.69 4.25
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.76 1.70 1.64 1.59 1.48 1.33 1.32 1.23 1.07 0.83 0.77
Accounts Receivable Turnover
6.78 6.98 6.29 5.89 5.71 5.22 5.49 5.39 5.55 5.32 5.43
Inventory Turnover
14.02 12.97 10.27 9.02 9.17 9.86 12.04 10.95 10.23 11.85 15.86
Fixed Asset Turnover
11.25 10.32 9.50 8.76 8.55 8.06 8.43 8.31 7.63 6.26 6.16
Accounts Payable Turnover
11.75 11.03 9.36 8.65 9.85 10.50 11.08 10.80 12.84 13.38 12.89
Days Sales Outstanding (DSO)
53.83 52.30 58.02 61.96 63.96 69.98 66.49 67.67 65.75 68.56 67.17
Days Inventory Outstanding (DIO)
26.03 28.14 35.55 40.47 39.80 37.03 30.33 33.35 35.68 30.81 23.01
Days Payable Outstanding (DPO)
31.06 33.10 39.00 42.20 37.05 34.75 32.94 33.80 28.43 27.28 28.31
Cash Conversion Cycle (CCC)
48.79 47.34 54.57 60.24 66.71 72.26 63.88 67.23 73.01 72.09 61.87
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
57 70 74 80 97 102 133 147 194 318 396
Invested Capital Turnover
2.35 2.26 2.16 2.10 1.96 1.74 1.74 1.64 1.52 1.09 0.93
Increase / (Decrease) in Invested Capital
11 13 3.75 6.22 17 5.11 31 14 47 124 77
Enterprise Value (EV)
0.00 0.00 0.00 186 217 423 605 704 953 714 761
Market Capitalization
0.00 0.00 0.00 166 187 396 558 656 984 683 666
Book Value per Share
$5.65 $6.21 $7.21 $8.27 $9.09 $10.08 $11.46 $13.18 $25.50 $30.82 $32.21
Tangible Book Value per Share
$0.23 $0.48 $1.84 $2.75 $2.38 $3.26 $0.85 $2.18 $11.28 $5.93 $0.51
Total Capital
58 71 74 81 97 103 135 149 229 320 401
Total Debt
19 27 23 21 30 28 48 49 4.16 33 100
Total Long-Term Debt
19 26 21 19 28 25 46 47 1.82 31 100
Net Debt
18 26 22 20 30 27 47 48 -31 31 95
Capital Expenditures (CapEx)
4.07 5.19 5.87 6.98 6.40 6.60 10 9.40 13 12 15
Debt-free, Cash-free Net Working Capital (DFCFNWC)
9.75 16 21 24 29 25 33 40 39 44 48
Debt-free Net Working Capital (DFNWC)
10 17 22 25 30 26 34 42 74 46 53
Net Working Capital (NWC)
10 16 19 23 28 24 32 39 72 44 53
Net Nonoperating Expense (NNE)
0.20 0.49 0.80 0.77 0.93 0.85 0.82 2.19 0.99 -0.36 3.55
Net Nonoperating Obligations (NNO)
18 26 22 20 30 27 47 48 -31 31 95
Total Depreciation and Amortization (D&A)
3.95 6.18 5.99 6.36 6.66 7.58 9.57 11 14 19 26
Debt-free, Cash-free Net Working Capital to Revenue
7.98% 11.41% 13.49% 14.90% 16.77% 14.59% 15.98% 17.35% 14.96% 15.90% 14.43%
Debt-free Net Working Capital to Revenue
8.50% 12.00% 13.86% 15.39% 17.05% 14.92% 16.66% 18.01% 28.52% 16.45% 15.92%
Net Working Capital to Revenue
8.50% 11.00% 12.48% 14.21% 15.91% 13.72% 15.61% 17.04% 27.62% 15.79% 15.92%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.60 $0.65 $0.83 $0.99 $1.10 $1.05 $1.52 $1.42 $1.66 $1.58 $0.58
Adjusted Weighted Average Basic Shares Outstanding
6.89M 6.99M 7.12M 7.20M 7.33M 7.42M 7.50M 7.55M 8.24M 9.19M 9.33M
Adjusted Diluted Earnings per Share
$0.58 $0.64 $0.81 $0.95 $1.08 $1.03 $1.50 $1.40 $1.63 $1.57 $0.57
Adjusted Weighted Average Diluted Shares Outstanding
7.12M 7.11M 7.30M 7.52M 7.49M 7.55M 7.59M 7.65M 8.35M 9.25M 9.38M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.99 $1.10 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
6.98M 7.11M 7.20M 7.30M 7.39M 7.47M 7.55M 7.64M 9.13M 9.32M 9.34M
Normalized Net Operating Profit after Tax (NOPAT)
4.33 5.01 6.73 7.91 9.00 8.64 12 13 15 14 8.93
Normalized NOPAT Margin
3.54% 3.48% 4.33% 4.92% 5.20% 4.99% 5.95% 5.58% 5.64% 5.08% 2.69%
Pre Tax Income Margin
4.92% 4.98% 5.12% 5.74% 5.62% 5.76% 6.44% 5.85% 7.11% 6.58% 2.41%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 17.28 6.58 10.61 22.93 2.73
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 15.06 5.33 7.98 17.74 1.94
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 4.89 2.69 3.37 7.77 -0.59
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 2.67 1.44 0.74 2.58 -1.38
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
3.25% 23.53% 7.60% 2.03% 34.98% 39.13% 58.73% 4.18% 35.95% 24.56% 8.72%

Quarterly Metrics And Ratios for Transcat

This table displays calculated financial ratios and metrics derived from Transcat's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 9/23/2023 12/23/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026
DEI Shares Outstanding
- - - - - - - 9,317,682.00 9,319,079.00 - 9,332,188.00
DEI Adjusted Shares Outstanding
- - - - - - - 9,317,682.00 9,319,079.00 - 9,332,188.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - 0.35 0.14 - 0.21
Growth Metrics
- - - - - - - - - - -
Revenue Growth
11.28% 13.53% 14.25% 10.08% 8.00% 2.44% 8.77% 14.57% 21.30% 25.62% 15.81%
EBITDA Growth
-15.12% 36.91% 49.38% 23.28% 58.69% -2.97% -4.27% 16.84% 23.75% -4.07% -9.29%
EBIT Growth
-45.23% 40.53% 54.72% 8.57% 107.03% -22.37% -26.91% 0.74% -5.99% -98.04% -37.36%
NOPAT Growth
-65.94% 41.18% 48.79% 18.20% 250.76% -53.00% -25.00% -11.31% -33.68% -96.11% -39.90%
Net Income Growth
-80.48% 109.12% 88.35% 49.47% 614.35% -29.60% -35.21% -26.02% -61.38% -146.71% -56.38%
EPS Growth
-80.65% 80.95% 68.75% 26.32% 483.33% -34.21% -39.51% -27.08% -60.00% -148.00% -59.18%
Operating Cash Flow Growth
164.29% 24.91% 92.44% 18.42% -18.98% 15.40% 85.58% -59.40% 88.46% -3.60% -41.65%
Free Cash Flow Firm Growth
-158.62% -113.10% -322.45% -533.56% -15.30% -208.31% -195.02% 4.80% -179.91% 41.93% 37.37%
Invested Capital Growth
33.79% 31.59% 31.88% 54.98% 30.29% 69.34% 63.83% 33.66% 62.22% 23.51% 24.36%
Revenue Q/Q Growth
3.64% 3.76% 8.82% -5.93% 1.68% -1.58% 15.55% -0.92% 7.65% 1.93% 6.52%
EBITDA Q/Q Growth
-32.39% 55.98% 77.47% -34.13% -12.97% -4.63% 63.79% -14.05% -7.82% -26.07% 54.88%
EBIT Q/Q Growth
-63.02% 136.70% 151.76% -50.73% -29.49% -11.25% 116.11% -25.51% -34.21% -98.15% 6,800.00%
NOPAT Q/Q Growth
-74.09% 257.19% 96.17% -34.89% -23.11% -52.14% 213.05% -23.00% -42.51% -97.19% 4,731.41%
Net Income Q/Q Growth
-84.40% 627.83% 105.79% -36.02% -25.45% -28.27% 89.39% -26.95% -61.09% -186.76% 276.84%
EPS Q/Q Growth
-84.21% 533.33% 113.16% -40.74% -27.08% -28.57% 96.00% -28.57% -60.00% -185.71% 266.67%
Operating Cash Flow Q/Q Growth
11.94% 29.41% -47.54% 55.82% -23.41% 84.32% -15.64% -65.91% 255.53% -5.71% -48.94%
Free Cash Flow Firm Q/Q Growth
-264.19% 11.37% 3.45% -103.29% 33.72% -136.99% 7.61% 34.40% -94.86% 50.83% 0.35%
Invested Capital Q/Q Growth
21.26% -1.21% 3.27% 25.27% 1.94% 28.40% -0.09% 2.20% 23.73% -2.25% 0.60%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
32.04% 32.13% 33.89% 33.96% 31.27% 29.48% 33.59% 33.79% 32.53% 30.11% 34.11%
EBITDA Margin
7.93% 11.92% 19.44% 13.61% 11.65% 11.29% 16.00% 13.88% 11.89% 8.62% 12.54%
Operating Margin
2.62% 6.59% 12.98% 7.64% 5.51% 3.15% 9.00% 6.98% 4.26% 0.10% 4.85%
EBIT Margin
2.69% 6.15% 14.22% 7.45% 5.16% 4.66% 8.71% 6.55% 4.00% 0.07% 4.71%
Profit (Net Income) Margin
0.73% 5.14% 9.72% 6.61% 4.84% 3.53% 5.79% 4.27% 1.54% -1.31% 2.18%
Tax Burden Percent
57.36% 78.39% 71.74% 84.32% 88.50% 75.33% 71.36% 71.43% 62.54% 76.51% 68.70%
Interest Burden Percent
47.40% 106.64% 95.25% 105.23% 105.99% 100.64% 93.11% 91.21% 61.62% -2,359.02% 67.33%
Effective Tax Rate
42.64% 21.61% 28.26% 15.68% 11.50% 24.67% 28.64% 28.57% 37.46% 0.00% 31.30%
Return on Invested Capital (ROIC)
2.19% 7.83% 14.16% 8.56% 6.02% 2.55% 6.98% 5.06% 2.48% 0.07% 3.10%
ROIC Less NNEP Spread (ROIC-NNEP)
1.25% 7.62% 17.62% 9.36% 5.89% 25.39% -574.06% -3.14% 0.33% -1.67% 1.47%
Return on Net Nonoperating Assets (RNNOA)
0.55% 0.42% 0.90% 0.68% 0.45% 0.34% -0.19% -0.08% 0.05% -0.39% 0.32%
Return on Equity (ROE)
2.74% 8.24% 15.05% 9.24% 6.47% 2.89% 6.79% 4.98% 2.53% -0.32% 3.41%
Cash Return on Invested Capital (CROIC)
-21.98% -19.71% -18.92% -35.45% -18.30% -45.27% -42.86% -23.99% -43.55% -17.95% -19.22%
Operating Return on Assets (OROA)
3.01% 6.56% 15.27% 7.51% 4.89% 3.80% 7.21% 5.27% 3.00% 0.05% 3.61%
Return on Assets (ROA)
0.82% 5.48% 10.43% 6.66% 4.59% 2.88% 4.79% 3.43% 1.15% -0.98% 1.67%
Return on Common Equity (ROCE)
2.74% 8.24% 15.05% 9.24% 6.47% 2.89% 6.79% 4.98% 2.53% -0.32% 3.41%
Return on Equity Simple (ROE_SIMPLE)
6.27% 4.77% 0.00% 5.76% 6.67% 6.03% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
0.94 3.37 6.60 4.30 3.31 1.58 4.95 3.81 2.19 0.06 2.98
NOPAT Margin
1.50% 5.17% 9.31% 6.45% 4.87% 2.37% 6.42% 4.99% 2.66% 0.07% 3.33%
Net Nonoperating Expense Percent (NNEP)
0.95% 0.21% -3.47% -0.80% 0.12% -22.84% 581.04% 8.20% 2.15% 1.74% 1.63%
Return On Investment Capital (ROIC_SIMPLE)
- 1.51% - - - 0.49% 1.55% 1.17% 0.54% 0.02% 0.74%
Cost of Revenue to Revenue
67.96% 67.87% 66.11% 66.04% 68.73% 70.52% 66.41% 66.21% 67.47% 69.89% 65.89%
SG&A Expenses to Revenue
18.51% 14.00% 9.82% 14.62% 13.70% 14.17% 12.62% 14.35% 15.35% 16.42% 16.70%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
29.43% 25.54% 20.91% 26.32% 25.76% 26.33% 24.60% 26.80% 28.27% 30.01% 29.26%
Earnings before Interest and Taxes (EBIT)
1.69 4.01 10 4.97 3.50 3.11 6.72 5.01 3.29 0.06 4.21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
4.98 7.77 14 9.08 7.90 7.54 12 11 9.78 7.23 11
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
5.28 4.35 4.37 4.17 4.13 3.47 2.38 2.70 2.32 1.85 2.21
Price to Tangible Book Value (P/TBV)
83.67 10.41 9.88 11.17 10.46 20.85 12.38 12.45 0.00 0.00 140.77
Price to Revenue (P/Rev)
3.01 3.79 3.79 4.12 4.11 3.58 2.45 2.74 2.27 1.72 2.01
Price to Earnings (P/E)
84.27 91.23 72.09 72.36 61.96 57.57 47.06 59.12 60.51 69.57 123.80
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
1.19% 1.10% 1.39% 1.38% 1.61% 1.74% 2.12% 1.69% 1.65% 1.44% 0.81%
Enterprise Value to Invested Capital (EV/IC)
4.11 4.89 4.91 4.42 4.40 3.18 2.25 2.53 1.97 1.64 1.92
Enterprise Value to Revenue (EV/Rev)
3.22 3.67 3.67 4.04 4.03 3.72 2.57 2.86 2.62 2.02 2.29
Enterprise Value to EBITDA (EV/EBITDA)
28.72 31.34 28.86 30.93 28.96 27.06 19.38 21.43 19.71 16.17 19.58
Enterprise Value to EBIT (EV/EBIT)
50.05 54.78 48.95 54.09 50.32 48.74 39.04 44.88 43.78 42.81 60.51
Enterprise Value to NOPAT (EV/NOPAT)
67.93 73.41 65.08 69.92 62.12 64.32 50.46 60.03 62.47 58.80 85.21
Enterprise Value to Operating Cash Flow (EV/OCF)
28.26 30.79 29.21 31.59 33.65 29.71 18.32 24.43 19.98 16.44 21.82
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.39 0.02 0.02 0.01 0.01 0.15 0.11 0.12 0.38 0.34 0.33
Long-Term Debt to Equity
0.37 0.01 0.01 0.00 0.00 0.14 0.11 0.11 0.38 0.34 0.33
Financial Leverage
0.44 0.05 0.05 0.07 0.08 0.01 0.00 0.02 0.15 0.23 0.21
Leverage Ratio
1.89 1.50 1.49 1.41 1.40 1.34 1.31 1.29 1.43 1.49 1.47
Compound Leverage Factor
0.89 1.60 1.42 1.49 1.49 1.34 1.22 1.18 0.88 -35.06 0.99
Debt to Total Capital
27.82% 2.12% 1.81% 1.35% 1.10% 12.97% 10.23% 10.52% 27.47% 25.18% 24.94%
Short-Term Debt to Total Capital
1.20% 1.04% 1.02% 0.89% 0.88% 0.75% 0.57% 0.37% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
26.63% 1.08% 0.79% 0.46% 0.23% 12.23% 9.67% 10.15% 27.47% 25.18% 24.94%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
72.18% 97.88% 98.19% 98.65% 98.90% 87.03% 89.77% 89.48% 72.53% 74.82% 75.06%
Debt to EBITDA
1.96 0.16 0.13 0.10 0.08 1.12 0.89 0.90 2.78 2.50 2.57
Net Debt to EBITDA
1.91 -1.04 -0.94 -0.55 -0.55 1.00 0.85 0.85 2.65 2.41 2.44
Long-Term Debt to EBITDA
1.87 0.08 0.06 0.04 0.02 1.06 0.84 0.86 2.78 2.50 2.57
Debt to NOPAT
4.63 0.38 0.28 0.23 0.17 2.66 2.31 2.51 8.81 9.10 11.19
Net Debt to NOPAT
4.52 -2.43 -2.12 -1.24 -1.19 2.37 2.20 2.37 8.41 8.78 10.64
Long-Term Debt to NOPAT
4.43 0.19 0.12 0.08 0.03 2.51 2.18 2.42 8.81 9.10 11.19
Altman Z-Score
5.57 10.71 11.17 12.15 13.66 6.77 5.42 6.02 3.23 2.94 3.36
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.32 3.37 3.14 2.96 3.59 2.42 2.29 2.92 2.43 2.21 2.33
Quick Ratio
1.64 2.70 2.49 2.23 2.77 1.80 1.70 2.21 1.93 1.73 1.79
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-47 -42 -40 -82 -54 -129 -119 -78 -152 -75 -75
Operating Cash Flow to CapEx
315.13% 298.69% 136.98% 242.90% 172.64% 439.11% 394.36% 78.80% 290.64% 453.34% 172.78%
Free Cash Flow to Firm to Interest Expense
-52.95 -515.64 0.00 -1,576.55 -714.94 -647.10 -252.60 -173.06 -119.85 -49.75 -54.04
Operating Cash Flow to Interest Expense
9.48 134.78 0.00 171.62 89.93 63.31 22.56 8.03 10.15 8.08 4.50
Operating Cash Flow Less CapEx to Interest Expense
6.47 89.65 0.00 100.96 37.84 48.89 16.84 -2.16 6.66 6.30 1.89
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.12 1.07 1.07 1.01 0.95 0.82 0.83 0.80 0.75 0.74 0.77
Accounts Receivable Turnover
5.70 6.10 5.55 5.82 5.74 5.64 5.32 5.40 5.37 5.70 5.43
Inventory Turnover
10.38 10.39 10.23 10.68 11.64 12.32 11.85 11.67 14.29 16.17 15.86
Fixed Asset Turnover
7.66 7.65 7.63 6.98 6.51 6.21 6.26 5.87 5.73 5.92 6.16
Accounts Payable Turnover
12.90 13.63 12.84 14.44 14.22 13.41 13.38 14.74 14.39 12.83 12.89
Days Sales Outstanding (DSO)
64.05 59.86 65.75 62.72 63.58 64.69 68.56 67.62 68.02 64.02 67.17
Days Inventory Outstanding (DIO)
35.15 35.14 35.68 34.18 31.36 29.63 30.81 31.29 25.55 22.57 23.01
Days Payable Outstanding (DPO)
28.29 26.78 28.43 25.29 25.67 27.22 27.28 24.76 25.37 28.46 28.31
Cash Conversion Cycle (CCC)
70.91 68.21 73.01 71.62 69.27 67.09 72.09 74.14 68.19 58.13 61.87
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
190 188 194 243 248 318 318 325 402 393 396
Invested Capital Turnover
1.46 1.52 1.52 1.33 1.24 1.08 1.09 1.01 0.93 0.90 0.93
Increase / (Decrease) in Invested Capital
48 45 47 86 58 130 124 82 154 75 77
Enterprise Value (EV)
782 920 953 1,074 1,090 1,012 714 823 794 646 761
Market Capitalization
730 950 984 1,093 1,111 975 683 790 687 549 666
Book Value per Share
$17.98 $24.75 $25.50 $28.72 $29.39 $30.55 $30.82 $31.40 $31.70 $31.81 $32.21
Tangible Book Value per Share
$1.14 $10.35 $11.28 $10.72 $11.62 $5.09 $5.93 $6.81 ($0.87) ($0.29) $0.51
Total Capital
192 223 229 266 272 323 320 327 407 397 401
Total Debt
53 4.73 4.16 3.58 3.00 42 33 34 112 100 100
Total Long-Term Debt
51 2.41 1.82 1.22 0.61 39 31 33 112 100 100
Net Debt
52 -30 -31 -19 -21 37 31 33 107 96 95
Capital Expenditures (CapEx)
2.68 3.66 4.18 3.67 3.96 2.87 2.70 4.60 4.43 2.68 3.59
Debt-free, Cash-free Net Working Capital (DFCFNWC)
38 37 39 42 47 43 44 52 45 41 48
Debt-free Net Working Capital (DFNWC)
39 72 74 65 71 47 46 54 50 44 53
Net Working Capital (NWC)
37 69 72 62 69 45 44 52 50 44 53
Net Nonoperating Expense (NNE)
0.48 0.02 -0.29 -0.11 0.02 -0.78 0.49 0.55 0.92 1.16 1.03
Net Nonoperating Obligations (NNO)
52 -30 -31 -19 -21 37 31 33 107 96 95
Total Depreciation and Amortization (D&A)
3.29 3.76 3.70 4.11 4.40 4.43 5.63 5.61 6.49 7.17 6.99
Debt-free, Cash-free Net Working Capital to Revenue
15.69% 14.59% 14.96% 15.87% 17.45% 15.67% 15.90% 17.95% 14.99% 12.74% 14.43%
Debt-free Net Working Capital to Revenue
16.20% 28.63% 28.52% 24.40% 26.25% 17.37% 16.45% 18.60% 16.67% 13.82% 15.92%
Net Working Capital to Revenue
15.26% 27.71% 27.62% 23.51% 25.37% 16.49% 15.79% 18.18% 16.67% 13.82% 15.92%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.06 $0.39 $0.82 $0.49 $0.36 $0.26 $0.47 $0.35 $0.14 ($0.12) $0.21
Adjusted Weighted Average Basic Shares Outstanding
7.82M 8.62M 8.24M 9.06M 9.16M 9.23M 9.19M 9.32M 9.32M 9.33M 9.33M
Adjusted Diluted Earnings per Share
$0.06 $0.38 $0.81 $0.48 $0.35 $0.25 $0.49 $0.35 $0.14 ($0.12) $0.20
Adjusted Weighted Average Diluted Shares Outstanding
7.95M 8.75M 8.35M 9.20M 9.28M 9.33M 9.25M 9.39M 9.40M 9.33M 9.38M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
8.83M 8.83M 9.13M 9.15M 9.20M 9.31M 9.32M 9.32M 9.33M 9.33M 9.34M
Normalized Net Operating Profit after Tax (NOPAT)
0.94 3.37 6.60 4.30 3.31 1.58 4.95 3.81 2.19 0.06 2.98
Normalized NOPAT Margin
1.50% 5.17% 9.31% 6.45% 4.87% 2.37% 6.42% 4.99% 2.66% 0.07% 3.33%
Pre Tax Income Margin
1.28% 6.55% 13.54% 7.84% 5.47% 4.69% 8.11% 5.97% 2.47% -1.72% 3.17%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
1.90 49.44 0.00 95.54 46.09 15.62 14.27 11.10 2.60 0.04 3.05
NOPAT to Interest Expense
1.06 41.56 0.00 82.68 43.49 7.95 10.51 8.46 1.73 0.04 2.16
EBIT Less CapEx to Interest Expense
-1.11 4.32 0.00 24.88 -6.00 1.21 8.54 0.90 -0.90 -1.74 0.45
NOPAT Less CapEx to Interest Expense
-1.95 -3.57 0.00 12.02 -8.60 -6.47 4.79 -1.74 -1.77 -1.74 -0.44
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
26.04% 21.67% 35.95% 41.20% 31.70% 34.63% 24.56% 14.56% 5.72% 5.75% 8.72%

Financials Breakdown Chart

Key Financial Trends

Transcat’s latest quarter shows continued revenue growth, but profitability and cash flow were mixed when viewed against the last several years. In Q4 2026, revenue rose to $89.3 million from $83.9 million a year earlier, and operating income improved to $4.3 million from $88,000 in Q3 2026. Net income rebounded to $1.9 million after a Q3 loss, though it remained well below Q4 2025’s $4.5 million.

Over the longer trend, the big picture is a company that has grown rapidly, but at the cost of heavier leverage and lower near-term margins. Revenue has climbed from $54.7 million in Q1 2023 to $89.3 million in Q4 2026, helped in part by acquisitions. At the same time, the balance sheet expanded significantly, especially goodwill and intangibles, while long-term debt also increased materially over the period.

  • Revenue has grown steadily over four years, reaching $89.3 million in Q4 2026 versus $54.7 million in Q1 2023.
  • Q4 2026 operating income improved sharply to $4.3 million, recovering from near breakeven in Q3 2026.
  • Operating cash flow remained solid in Q4 2026 at $6.2 million, showing the business still converts earnings into cash.
  • For the full quarter, gross profit rose to $30.5 million, up from $25.3 million in Q3 2026, indicating better top-line momentum.
  • The company ended Q3 2026 with $296.8 million in equity, a much larger equity base than two years earlier.
  • Share count has been relatively controlled recently, with diluted weighted average shares in Q4 2026 at 9.38 million versus 9.52 million in Q1 2023.
  • Recent results show acquisition-driven growth, which can support scale but also makes organic performance harder to judge.
  • Goodwill and intangible assets make up a large portion of total assets, reflecting an M&A-heavy growth strategy.
  • Interest expense remains meaningful, with $1.4 million of interest expense in Q4 2026 despite debt paydown activity.
  • Q4 2026 net income of $1.9 million was down sharply from $4.5 million in Q4 2025.
  • Q3 2026 was weak, with a net loss of $1.1 million and operating income of only $88,000.
  • Operating cash flow in Q4 2026 was pressured by a large $8.4 million swing in operating assets and liabilities, which offset otherwise healthy earnings.
  • Long-term debt has risen substantially versus early 2023, and leverage appears to be a lasting consideration for investors.
  • Acquisitions have driven major balance sheet growth, but they also increase integration and goodwill risk if results disappoint.

Balance sheet trends are the key watch item. Total assets rose to $472.9 million in Q3 2026 from $182.0 million in Q1 2023, while goodwill increased to $218.3 million. That suggests Transcat has been using acquisitions to expand, but it also means a meaningful share of assets is not hard tangible capital. Meanwhile, total liabilities also rose to $176.1 million in Q3 2026, up from $92.5 million in Q1 2023.

Bottom line: Transcat still looks like a growth story with decent operating cash generation, but the last four years show a business that has become more acquisition-dependent and more leveraged. Investors will likely want to see sustained margin improvement, stronger organic revenue growth, and continued discipline on debt before assigning a premium valuation.

06/16/26 11:39 AM ETAI Generated. May Contain Errors.

Transcat Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Transcat's fiscal year ends in March. Their fiscal year 2026 ended on March 28, 2026.

Transcat's net income appears to be on an upward trend, with a most recent value of $5.38 million in 2026, rising from $4.12 million in 2016. The previous period was $14.52 million in 2025. Check out Transcat's forecast to explore projected trends and price targets.

Transcat's total operating income in 2026 was $13.26 million, based on the following breakdown:
  • Total Gross Profit: $108.30 million
  • Total Operating Expenses: $95.04 million

Over the last 10 years, Transcat's total revenue changed from $122.17 million in 2016 to $331.88 million in 2026, a change of 171.7%.

Transcat's total liabilities were at $179.87 million at the end of 2026, a 82.9% increase from 2025, and a 375.9% increase since 2016.

In the past 10 years, Transcat's cash and equivalents has ranged from $499 thousand in 2020 to $19.65 million in 2024, and is currently $4.94 million as of their latest financial filing in 2026.

Over the last 10 years, Transcat's book value per share changed from 5.65 in 2016 to 32.21 in 2026, a change of 470.2%.



Financial statements for NASDAQ:TRNS last updated on 5/31/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners